InMode

InMode is a medical technology firm that designs, develops, manufactures, and markets medical solutions that use energy. The products of the company are utilized in minimally invasive aesthetic and medical operations. InMode provides a comprehensive range of innovative solutions for surgical, non-surgical, and minimally invasive face and body treatments. BodyTite, FaceTite, Morpheus8, Evoke, and AccuTite are some of their most popular items.

Radiofrequency technology is used in these items to send precise, regulated energy to specific parts of the body, resulting in better skin tone, texture, and contouring. InMode is headquartered in Israel and maintains offices in the United States, Europe, Asia, and Latin America.

BodyTite is one of InMode's most popular products. Radiofrequency-assisted liposuction (RFAL) is used in this gadget to remove excess fat and tighten the skin. BodyTite can be applied to virtually any portion of the body, including the abdomen, thighs, arms, and back. FaceTite, another popular product, uses the same RFAL technology to tighten skin and decrease the appearance of wrinkles on the face and neck.

The Morpheus8 by InMode is a fractional radiofrequency device that can be used to improve skin texture, eliminate fine lines and wrinkles, and stimulate collagen formation. Evoke is a non-invasive facial remodeling technology that tightens the skin and improves facial shapes by using radiofrequency energy. AccuTite is a minimally invasive device for treating tiny areas of the face and body, such as the chin and jowls.

Inmode reported revenue of $227.8 million in 2020, an increase of 16.7% from the year before. The business's net income increased 1.3% from the prior year to $70.6 million. Additionally, the business reported having $154.3 million in cash on hand and no long-term debt. InMode announced earnings of about $431.2 million for the 2023 fiscal year.

Founded: 2008

Headquarters: Tavor Building Sha'ar Yokneam PO Box 533, Yokneam, Isreal

Website: https://inmodemd.com/